PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.36%
Revenue growth of 30.36% while CSIQ is flat. Bruce Berkowitz would check if a small edge can widen further.
101.11%
Positive gross profit growth while CSIQ is negative. John Neff would see a clear operational edge over the competitor.
665.55%
Positive EBIT growth while CSIQ is negative. John Neff might see a substantial edge in operational management.
665.55%
Positive operating income growth while CSIQ is negative. John Neff might view this as a competitive edge in operations.
2011.37%
Positive net income growth while CSIQ is negative. John Neff might see a big relative performance advantage.
1804.76%
Positive EPS growth while CSIQ is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2005.26%
Positive diluted EPS growth while CSIQ is negative. John Neff might view this as a strong relative advantage in controlling dilution.
4.77%
Slight or no buybacks while CSIQ is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.70%
Slight or no buyback while CSIQ is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
169.34%
OCF growth of 169.34% while CSIQ is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
68.26%
FCF growth of 68.26% while CSIQ is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-8.27%
Negative 10Y revenue/share CAGR while CSIQ stands at 850.55%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-8.27%
Negative 5Y CAGR while CSIQ stands at 850.55%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-8.27%
Negative 3Y CAGR while CSIQ stands at 850.55%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-93.35%
Negative 10Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-93.35%
Negative 5Y OCF/share CAGR while CSIQ is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-93.35%
Negative 3Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
123.37%
Positive 10Y CAGR while CSIQ is negative. John Neff might see a substantial advantage in bottom-line trajectory.
123.37%
Positive 5Y CAGR while CSIQ is negative. John Neff might view this as a strong mid-term relative advantage.
123.37%
Positive short-term CAGR while CSIQ is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.43%
AR growth of 38.43% while CSIQ is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
24.59%
Inventory growth of 24.59% while CSIQ is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
63.80%
Asset growth of 63.80% while CSIQ is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
70.33%
BV/share growth of 70.33% while CSIQ is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
29.66%
R&D growth of 29.66% while CSIQ is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
13.79%
SG&A growth of 13.79% while CSIQ is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.